JPH0346471B2 - - Google Patents
Info
- Publication number
- JPH0346471B2 JPH0346471B2 JP59027989A JP2798984A JPH0346471B2 JP H0346471 B2 JPH0346471 B2 JP H0346471B2 JP 59027989 A JP59027989 A JP 59027989A JP 2798984 A JP2798984 A JP 2798984A JP H0346471 B2 JPH0346471 B2 JP H0346471B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- compounds
- formula
- activity
- rats
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH862/83A CH652719A5 (en) | 1983-02-16 | 1983-02-16 | Ergoline derivatives, their preparation and use |
| CH863/83 | 1983-02-16 | ||
| CH862/83 | 1983-02-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59155382A JPS59155382A (ja) | 1984-09-04 |
| JPH0346471B2 true JPH0346471B2 (pm) | 1991-07-16 |
Family
ID=4196915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59027989A Granted JPS59155382A (ja) | 1983-02-16 | 1984-02-15 | 麦角アルカロイド誘導体 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS59155382A (pm) |
| CH (1) | CH652719A5 (pm) |
| ZA (1) | ZA841150B (pm) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2656344A1 (de) * | 1975-12-23 | 1977-07-07 | Sandoz Ag | Ergolinderivate, ihre verwendung und herstellung |
-
1983
- 1983-02-16 CH CH862/83A patent/CH652719A5/de not_active IP Right Cessation
-
1984
- 1984-02-15 JP JP59027989A patent/JPS59155382A/ja active Granted
- 1984-02-16 ZA ZA841150A patent/ZA841150B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA841150B (en) | 1985-09-25 |
| CH652719A5 (en) | 1985-11-29 |
| JPS59155382A (ja) | 1984-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4877620A (en) | Ibuprofen-containing medicament | |
| US3795739A (en) | Treatment of parkinson disease | |
| EP0867179B1 (en) | Composition of L-DOPA esters | |
| JP2009537565A (ja) | R(+)およびs(−)プラミペキソール組成とそれを利用する方法 | |
| JPH06102623B2 (ja) | 中枢神経興奮剤 | |
| US6310085B1 (en) | Method for the treatment of neurological or neuropsychiatric disorders | |
| CZ282085B6 (cs) | Organické soli N,N'-diacetylcystinu | |
| AU782492B2 (en) | Method for the treatment of neurological or neuropsychiatric disorders | |
| US4330558A (en) | Pharmaceutical composition and method for treating peripheral orthostatic hypotension | |
| EP0317269B1 (en) | Antiparkinson ergoline derivatives | |
| RU2213560C2 (ru) | Фармацевтическая композиция, содержащая сочетание правовращающего и левовращающего изомеров соталола | |
| US3557292A (en) | Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine | |
| EP0207011B1 (en) | Use of some alkanoyl l-carnitines for the manufacture of a medicament for therapeutical treatment of idiopathic and induced parkinsonism | |
| US5519057A (en) | Ibuprofen-containing medicament | |
| EP0391971A1 (en) | IMPROVED TOXICITY CURVES IN CHEMOTHERAPY. | |
| JPH0346471B2 (pm) | ||
| US3155584A (en) | Compositions and method of inhibiting monoamine oxidase and treating hypertension | |
| US3362879A (en) | Tyrosine tranquilizing compositions and methods of treatment | |
| US3701829A (en) | Treatment of parkinson's disease | |
| EP0132880B1 (en) | Pharmaceutical compositions containing epinine or a pharmaceutically acceptable salt thereof | |
| US4855325A (en) | Treatment of mammals suffering from damage to the central nervous system | |
| US4645770A (en) | Agent for treating Parkinson's disease or Parkinsonism | |
| US3574852A (en) | Treating depression with the n-oxide of n-(3' - dimethylamino propyl)-iminodibenzyl | |
| NZ258591A (en) | Use of idazoxan and derivatives thereof in a medicament for treating parkinsons disease | |
| JPH09500375A (ja) | パーキンソン病の治療を目的とする医薬品の製造のためのエファロキサンおよびその誘導体の使用 |